In post-mortem studies of AD patient brains, plasma membrane proteasome localization was lower in those with greater expression of APOE4 compared to APOE3, and inhibition of the plasma membrane proteasome increased tau aggregation (Paradise et al., 2022). Here, MAPT is linked to Alzheimer disease.